As shown in Figure 3, the percentage of leukemic blasts from patients with B-ALL at diagnosis in late apoptosis (% of Annexin V+/7AAD− cells, mean ± SE 23.81 ± 6.99) was significantly increased by OLE at 200 μM (72 ± 6.53, p = 0.05) and 400 μM (81.91 ± 0.56, p = 0.05). The gene discussed is ANXA5; the disease is acute lymphoblastic leukemia.